Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

TERAZOSIN

CompanyNorthwind Pharmaceuticals, LLC (DUNS: 036986393)

Effective Date

March 19, 2015

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Terazosin(5 mg in 1 1)

Registrants (1)

Northwind Pharmaceuticals, LLC

DUNS Number

036986393

Manufacturing Establishments (1)

Northwind Pharmaceuticals, LLC

Labeler

Northwind Pharmaceuticals, LLC

Registrant

Northwind Pharmaceuticals, LLC

DUNS Number

036986393

Products (1)

TERAZOSIN

NDC Product Code

51655-676

Application Number

ANDA075317

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

March 19, 2015

Ingredients

TerazosinActive

Code: D32S14F082Class: ACTIMQuantity: 5 mg in 1 1

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy